Literature DB >> 3728313

Cardiovascular anomalies in DiGeorge syndrome and importance of neural crest as a possible pathogenetic factor.

L H Van Mierop, L M Kutsche.   

Abstract

One hundred sixty-one cases of DiGeorge syndrome (111 previously reported in which details concerning individual patients were given and 50 observed) were analyzed for occurrence and type of cardiovascular anomalies. Only 5 patients had a normal heart. Interrupted aortic arch type B was the major anomaly in 48 patients and persistent truncus arteriosus in 37. Therefore, in about half of the patients with DiGeorge syndrome the major anomaly was one that is rare. Conversely, of those patients with interrupted aortic arch, 68% had DiGeorge syndrome, as did 33% of all patients with truncus arteriosus. Although tetralogy of Fallot was also seen often in DiGeorge syndrome (10 patients), these cases represented less than 2% of the total number of cases of tetralogy of Fallot. Similarly, less than 1% of children with isolated ventricular septal defect or transposition of the great arteries had DiGeorge syndrome. The primary cardiovascular anomaly always involved the aortic arch system or the arterial pole of the heart. Recent studies show that neural crest cells play a crucial role in development of pharyngeal (bronchial) pouch derivatives, e.g., thymus and parathyroid glands, as well as the aortic arches and the truncoconal part of the heart. These studies and present observations support the view that DiGeorge syndrome and the associated cardiovascular anomalies are due to an abnormal developmental process involving the neural crest. Curiously, no instances of aortopulmonary septal defect or anomalous origin of a pulmonary artery from the ascending aorta (hemitruncus) have been associated with DiGeorge syndrome.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1986        PMID: 3728313     DOI: 10.1016/0002-9149(86)90256-0

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  62 in total

Review 1.  Genetics in bicuspid aortic valve disease: Where are we?

Authors:  Katia Bravo-Jaimes; Siddharth K Prakash
Journal:  Prog Cardiovasc Dis       Date:  2020-06-27       Impact factor: 8.194

2.  Recurrence risk figures for isolated tetralogy of Fallot after screening for 22q11 microdeletion.

Authors:  M C Digilio; B Marino; A Giannotti; A Toscano; B Dallapiccola
Journal:  J Med Genet       Date:  1997-03       Impact factor: 6.318

3.  Interrupted Aortic Arch.

Authors:  Satinder K. Sandhu; Timothy W. Pettitt
Journal:  Curr Treat Options Cardiovasc Med       Date:  2002-08

4.  Truncus arteriosus and double aortic arch associated with DiGeorge syndrome.

Authors:  G Pacileo; G Palma; M G Russo; C Vosa; R Calabrò
Journal:  Tex Heart Inst J       Date:  1991

Review 5.  Cardiovascular embryology.

Authors:  R Abdulla; G A Blew; M J Holterman
Journal:  Pediatr Cardiol       Date:  2004 May-Jun       Impact factor: 1.655

6.  Giant aortic arch aneurysm after interrupted aortic arch repair.

Authors:  Alakananda Ghosh; Amy Liu; Bassem Mora; Brojendra Agarwala
Journal:  Pediatr Cardiol       Date:  2010-08-10       Impact factor: 1.655

7.  Interrupted aortic arch with aberrant subclavian artery: a rare form of arch anomaly demonstrated with multidetector CT and 3D reconstruction.

Authors:  Ho Yun Lee; Whal Lee; Jin Wook Chung; Jae Hyung Park; Kyung Mo Yeon
Journal:  Pediatr Radiol       Date:  2006-01-11

8.  Noonan's and DiGeorge syndromes with monosomy 22q11.

Authors:  D I Wilson; S B Britton; C McKeown; D Kelly; I E Cross; S Strobel; P J Scambler
Journal:  Arch Dis Child       Date:  1993-02       Impact factor: 3.791

9.  Prenatal diagnosis of truncus arteriosus using multiplanar display in 4D ultrasonography.

Authors:  Francesca Gotsch; Roberto Romero; Jimmy Espinoza; Juan Pedro Kusanovic; Offer Erez; Sonia Hassan; Lami Yeo
Journal:  J Matern Fetal Neonatal Med       Date:  2010-04

10.  22q11 deletions in isolated and syndromic patients with tetralogy of Fallot.

Authors:  F Amati; A Mari; M C Digilio; R Mingarelli; B Marino; A Giannotti; G Novelli; B Dallapiccola
Journal:  Hum Genet       Date:  1995-05       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.